Eric M. Blalock

Dr. Eric M. Blalock


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2003 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
XPXuejun Peng
Xuejun Peng
CWConstance L Wood
Constance L Wood
EBEric M. Blalock
Eric M. Blalock
KCKuey Chu Chen
Kuey Chu Chen
PLPhilip W Landfield
Philip W Landfield
ASArnold J Stromberg
Arnold J Stromberg
Microarray technology has become a very important tool for studying gene expression profiles under various conditions. Biologists often pool RNA samples extracted from different subjects onto a single microarray chip to help defray the cost of microarray experiments as well as to correct for the technical difficulty in getting sufficient RNA from a single subject. However, the statistical, technical and financial implications of pooling have not been explicitly investigated. Modeling the resulting gene expression from sample pooling as a mixture of individual responses, we derived expressions for the experimental error and provided both upper and lower bounds for its value in terms of the variability among individuals and the number of RNA samples pooled. Using "virtual" pooling of data from real experiments and computer simulations, we investigated the statistical properties of RNA sample pooling. Our study reveals that pooling biological samples appropriately is statistically valid and efficient for microarray experiments. Furthermore, optimal pooling design(s) can be found to meet statistical requirements while minimizing total cost. Appropriate RNA pooling can provide equivalent power and improve efficiency and cost-effectiveness for microarray experiments with a modest increase in total number of subjects. Pooling schemes in terms of replicates of subjects and arrays can be compared before experiments are conducted.

1 October 2011 in Journal of Chemical Neuroanatomy
Verified
Journal Article
Closed access
EBEric M. Blalock
Eric M. Blalock
HBHeather M. Buechel
Heather M. Buechel
JPJelena Popovic
Jelena Popovic
JGJames W. Geddes
James W. Geddes
PLPhilip W. Landfield
Philip W. Landfield

1 November 2005 in Ageing Research Reviews
Verified
Journal Article
Closed access
EBEric M. Blalock
Eric M. Blalock
KCK.-C. Chen
K.-C. Chen
ASA.J. Stromberg
A.J. Stromberg
CNC.M. Norris
C.M. Norris
IKI. Kadish
I. Kadish
PLP.W. Landfield
P.W. Landfield

1 March 2017 in Behavioural Brain Research
Verified
Journal Article
Open access
KHKendra E Hargis
Kendra E Hargis
EBEric M. Blalock
Eric M. Blalock
Aging is the biggest risk factor for idiopathic Alzheimer's disease (AD). Recently, the National Institutes of Health released AD research recommendations that include: appreciating normal brain aging, expanding data-driven research, using open-access resources, and evaluating experimental reproducibility. Transcriptome data sets for aging and AD in humans and animal models are available in NIH-curated, publically accessible databases. However, little work has been done to test for concordance among those molecular signatures. Here, we test the hypothesis that brain transcriptional profiles from animal models recapitulate those observed in the human condition. Raw transcriptional profile data from twenty-nine studies were analyzed to produce p-values and fold changes for young vs. aged or control vs. AD conditions. Concordance across profiles was assessed at three levels: (1) # of significant genes observed vs. # expected by chance; (2) proportion of significant genes showing directional agreement; (3) correlation among studies for magnitude of effect among significant genes. The highest concordance was found within subjects across brain regions. Normal brain aging was concordant across studies, brain regions, and species, despite profound differences in chronological aging among humans, rats and mice. Human studies of idiopathic AD were concordant across brain structures and studies, but were not concordant with the transcriptional profiles of transgenic AD mouse models. Further, the five transgenic AD mouse models that were assessed were not concordant with one another. These results suggest that normal brain aging is similar in humans and research animals, and that different transgenic AD model mice may reflect selected aspects of AD pathology.

1 August 2013 in Neurobiology of Aging
Verified
Journal Article
Closed access
TPTristano Pancani
Tristano Pancani
KAKatie L. Anderson
Katie L. Anderson
LBLawrence D. Brewer
Lawrence D. Brewer
IKInga Kadish
Inga Kadish
CDChris DeMoll
Chris DeMoll
OTOlivier THIBAULT
Olivier THIBAULT

28 April 2010 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
EBEric M. Blalock
Eric M. Blalock
RGRichard Grondin
Richard Grondin
KCKuey-Chu Chen
Kuey-Chu Chen
OTOlivier Thibault
Olivier Thibault
VTVeronique Thibault
Veronique Thibault
PLPhilip W. Landfield
Philip W. Landfield
Age-dependent metabolic syndrome (MetS) is a well established risk factor for cardiovascular disease, but it also confers major risk for impaired cognition in normal aging or Alzheimer's disease (AD). However, little is known about the specific pathways mediating MetS–brain interactions. Here, we performed the first studies quantitatively linking MetS variables to aging changes in brain genome-wide expression and mitochondrial function. In six young adult and six aging female rhesus monkeys, we analyzed gene expression in two major hippocampal subdivisions critical for memory/cognitive function [hippocampus proper, or cornu ammonis (CA), and dentate gyrus (DG)]. Genes that changed with aging [aging-related genes (ARGs)] were identified in each region. Serum variables reflecting insulin resistance and dyslipidemia were used to construct a quantitative MetS index (MSI). This MSI increased with age and correlated negatively with hippocampal mitochondrial function (state III oxidation). More than 2000 ARGs were identified in CA and/or DG, in approximately equal numbers, but substantially more ARGs in CA than in DG were correlated selectively with the MSI. Pathways represented by MSI-correlated ARGs were determined from the Gene Ontology Database and literature. In particular, upregulated CA ARGs representing glucocorticoid receptor (GR), chromatin assembly/histone acetyltransferase, and inflammatory/immune pathways were closely associated with the MSI. These results suggest a novel model in which MetS is associated with upregulation of hippocampal GR-dependent transcription and epigenetic coactivators, contributing to decreased mitochondrial function and brain energetic dysregulation. In turn, these MSI-associated neuroenergetic changes may promote inflammation, neuronal vulnerability, and risk of cognitive impairment/AD.